EVP, Chief Financial Officer
Tue, Mar 4, 2025
Mar 4
exercised or converted securities in TEVA
33,512 shares @ $0.00
Decreased holdings by -50.00%
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Health CarePharmaceuticals
1D0.00%
1W+0.96%
1M+19.47%
3M+6.36%
6M—
1Y—